Medical AI Alliance
← Company Index
Pharma & CDMOKOSPI 017180430 approvals55 trials

MYUNGMOON PHARM CO.,LTD

Official website

Myungmoon Pharm, founded in 1983 and KOSPI-listed in 2008, manufactures finished and raw pharmaceuticals including hyperlipidemia treatments.

As of 2026-10-10, MYUNGMOON PHARM CO.,LTD has 1 Korean MFDS device approval, 429 Korean MFDS drug approvals, 1 PubMed-indexed paper on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1983 and listed on KOSPI in 2008, Myungmoon Pharm manufactures and sells finished and raw material pharmaceuticals. It produces the hyperlipidemia treatments Nopid Capsule, Rosette Tab, and Myungmoon Rosuvastatin Calcium Tab, the degenerative joint disease treatment Myungmoon Atroda Capsule, and the anti-inflammatory analgesic Trapen Tab, while distributing products such as the brain function improvement drug Neuraren Tab. In its 40th fiscal period, consolidated revenue reached KRW 195.2 billion, with R&D spending of KRW 5.1 billion (about 2.61% of revenue) funding the hyperlipidemia generic MMP-320 and the improved new drug MMP-305.

Regulatory approvals

data.go.kr

429 Korean MFDS drug approvals · 1982–2026 / 1 Korean MFDS device approvals · 2020

  • MFDS drugMyungmoon UDCA Tab 50mg2026-10-02
    Drug · OTC · Approval202603004
  • MFDS drugCreas Tablet 250002026-09-15
    Drug · OTC · Approval202602786
  • MFDS drugLixanaban Tab. 60mg2026-08-27
    Drug · Prescription · Approval202602504
  • MFDS drugLixanaban Tab. 30mg2026-08-27
    Drug · Prescription · Approval202602505
  • MFDS drugLixanaban Tab. 15mg2026-08-27
    Drug · Prescription · Approval202602506
  • MFDS drugPitafenochol SR Tab.2026-02-26
    Drug · Prescription · Approval202600583
  • MFDS drugMycal U Tab.2025-12-23
    Drug · OTC · Notification202503371
  • MFDS drugSubsidiary: 명문바이오(주)Lefvio Tab 20mg(Leflunomide)2025-09-19
    Drug · Prescription · Approval202502497
  • MFDS drugMycal U Tab.Revoked2025-08-13
    Drug · OTC · Notification202502091
  • MFDS drugCandesan-S Tab2025-07-22
    Drug · Prescription · Approval202501846
  • MFDS drugCANDESAN-A TAB2025-07-22
    Drug · Prescription · Approval202501847
  • MFDS drugCANDESAN-S TAB2025-07-22
    Drug · Prescription · Approval202501848
Show 68 more
  • MFDS drugSubsidiary: 명문바이오(주)마이봄액(L-아스파르트산-L-아르기닌수화물)2025-07-01
    Drug · OTC · Notification202501628
  • MFDS drugRozet Tab. 10/2.5mg2025-06-17
    Drug · Prescription · Approval202501472
  • MFDS drugCrea Forte Tablet 600002025-04-18
    Drug · OTC · Notification202500929
  • MFDS drugCrea Basic Tablet 250002025-04-14
    Drug · OTC · Notification202500868
  • MFDS drugSubsidiary: 명문바이오(주)Memantamax Tab. 20mg2025-04-14
    Drug · Prescription · Approval202500882
  • MFDS drugLanstar Tab. 15/600mg2025-03-14
    Drug · Prescription · Approval202500564
  • MFDS drugCrea Tablet 400002025-01-02
    Drug · OTC · Notification202500003
  • MFDS drugLabesin Injection 100mg2024-11-27
    Drug · Prescription · Approval202402816
  • MFDS drugMyungmoon UDCA Tab 100mg2024-11-07
    Drug · OTC · Notification202402632
  • MFDS drugGinkgolomin Tab. 240mg(Ginkgo Leaf Dried Extract)2024-10-07
    Drug · OTC · Notification202402380
  • MFDS drugMycal D Mini Tab2024-08-26
    Drug · OTC · Notification202402042
  • MFDS drugMycal Q Mini Tab2024-08-21
    Drug · OTC · Notification202402022
  • MFDS drugSubsidiary: 명문바이오(주)Vita CD Tablets2024-06-05
    Drug · OTC · Notification202401409
  • MFDS drugMyungmoon Linagliptin Duo SR Tab 2.5/1000mg2024-03-22
    Drug · Prescription · Approval202400616
  • MFDS drugMyungmoon Linagliptin Duo SR Tab 5/1000mg2024-03-22
    Drug · Prescription · Approval202400617
  • MFDS drugTelmionceplus Tab.40/5/5mg2023-09-25
    Drug · Prescription · Approval202302810
  • MFDS drugTelmionceplus Tab. 80/5/5mg2023-09-25
    Drug · Prescription · Approval202302811
  • MFDS drugEMPIANCE DUO TAB 12.5/500mg2023-09-12
    Drug · Prescription · Approval202302723
  • MFDS drugEMPIANCE DUO TAB 12.5/1000mg2023-09-12
    Drug · Prescription · Approval202302724
  • MFDS drugEMPIANCE DUO TAB 12.5/850mg2023-09-12
    Drug · Prescription · Approval202302725
  • MFDS drugCeletec tab.2023-08-10
    Drug · Prescription · Approval202302403
  • MFDS drugMyungmoon Pethidine HCl Inj.2023-06-19
    Drug · Prescription · Approval202301862
  • MFDS drugprilin tab 50mg2023-04-26
    Drug · Prescription · Approval202301367
  • MFDS drugprilin tab 25mg2023-04-26
    Drug · Prescription · Approval202301368
  • MFDS drugMycal-Q Tab.2023-03-16
    Drug · OTC · Notification202300936
  • MFDS drugNewcatine Tab.2023-02-13
    Drug · Prescription · Notification202300523
  • MFDS drugPhenacol Tab. 500mg2023-02-06
    Drug · OTC · Notification202300455
  • MFDS drugForglo Tab. 5mg2023-01-31
    Drug · Prescription · Approval202300404
  • MFDS drugForglo M XR Tab. 10/1000mg2023-01-27
    Drug · Prescription · Approval202300357
  • MFDS drugLanstar Tab. 30/600mg2023-01-09
    Drug · Prescription · Approval202300177
  • MFDS drugIBUCOLDBEN Tab.200mg(Ibuprofen)2022-12-29
    Drug · OTC · Notification202204696
  • MFDS drugDamocare Plus Tab.2022-12-23
    Drug · Prescription · Approval202204627
  • MFDS drugBepotaon SR Tab.2022-12-21
    Drug · Prescription · Approval202204552
  • MFDS drugMycal-F Tab.2022-12-07
    Drug · OTC · Notification202204405
  • MFDS drugForglo Tab. 10mg2022-11-07
    Drug · Prescription · Approval202204016
  • MFDS drugEPESINACE TAB.2022-09-22
    Drug · Prescription · Approval202203632
  • MFDS drugIBUCOLDBEN Soft Cap.400mg(ibuprofen)2022-08-17
    Drug · OTC · Notification202203304
  • MFDS drugSugadine Inj.2022-07-06
    Drug · Prescription · Approval202202799
  • MFDS drugEMPIANCE DUO TAB 5/1000mg2022-04-04
    Drug · Prescription · Approval202201373
  • MFDS drugEMPIANCE DUO TAB 5/850mg2022-04-04
    Drug · Prescription · Approval202201374
  • MFDS drugEMPIANCE DUO TAB 5/500mg2022-04-04
    Drug · Prescription · Approval202201375
  • MFDS drugMyungmoon Damocare 1.3 milligram Tab2022-03-21
    Drug · Prescription · Approval202201129
  • MFDS drugDANG E JANU COMBI TAB 50/500mg2022-01-24
    Drug · Prescription · Approval202200404
  • MFDS drugDANG E JANU COMBI TAB 50/850mg2022-01-24
    Drug · Prescription · Approval202200405
  • MFDS drugDANG E JANU COMBI TAB 50/1000mg2022-01-24
    Drug · Prescription · Approval202200406
  • MFDS drugDapajanu Tab. 10/100mg2022-01-04
    Drug · Prescription · Approval202200067
  • MFDS drugVancomycin HCl Injection 1g Myungmoon2021-09-30
    Drug · Prescription · Notification202106709
  • MFDS drugVancomycin HCl Injection 500g MyungmoonRevoked2021-09-30
    Drug · Prescription · Notification202106710
  • MFDS drugMyungmoon Damocare Tab.2021-04-28
    Drug · Prescription · Approval202103463
  • MFDS drugPancrea Tab.2021-04-05
    Drug · OTC · Notification202102900
  • MFDS drugEparlet Tab. 50mg2021-03-24
    Drug · Prescription · Notification202102567
  • MFDS drugEMPIANCE TAB 25mgRevoked2021-03-05
    Drug · Prescription · Approval202102093
  • MFDS drugEMPIANCE TAB 10mgRevoked2021-03-05
    Drug · Prescription · Approval202102094
  • MFDS drugEzeto Tab 10/40mg2021-02-18
    Drug · Prescription · Approval202101558
  • MFDS drugEzeto Tab 10/20mg2021-02-18
    Drug · Prescription · Approval202101559
  • MFDS drugEzeto Tab 10/10mg2021-02-18
    Drug · Prescription · Approval202101560
  • MFDS drugCeresin Inj.Revoked2021-01-05
    Drug · Prescription · Notification202100068
  • MFDS drugMyungmoon Pitavastatin Tab 4mgRevoked2020-12-31
    Drug · Prescription · Approval202009439
  • MFDS drugMyungmoon Pitavastatin Tab 2mgRevoked2020-12-31
    Drug · Prescription · Approval202009440
  • MFDS drugMyungmoon Pitavastatin Tab 1mgRevoked2020-12-31
    Drug · Prescription · Approval202009441
  • MFDS drugNafam Inj. 102020-09-24
    Drug · Prescription · Approval202006590
  • MFDS drugNafam Inj. 102020-09-24
    Drug · Prescription · Approval202006591
  • MFDSSubsidiary: 명문바이오(주)Centrifuge, low-/medium-speed, cytological2020-06-24
    Product approval · Class 1체외 수신 20-1516 호
  • MFDS drugJabaroxa Tab 2.5mg2020-05-29
    Drug · Prescription · Approval202004023
  • MFDS drugDANG E JANU TAB 25mg2020-05-29
    Drug · Prescription · Approval202004043
  • MFDS drugDANG E JANU TAB 50mg2020-05-29
    Drug · Prescription · Approval202004044
  • MFDS drugDANG E JANU TAB 100mg2020-05-29
    Drug · Prescription · Approval202004045
  • MFDS drugValsarove Tab 5/80mg2020-05-26
    Drug · Prescription · Approval202003852

Showing the 80 most recent of 430 records.

Clinical trials

data.go.kr

55 MFDS clinical trial authorisations · 2012–2025 (Bioequivalence 47 · Phase 1 6 · Phase 3 2)

  • Phase 1MMP-1232025-10-21

    2 trial sites

  • BioequivalenceMMP-1142025-08-11

    2 trial sites

  • Phase 1MMP-1162024-12-10

    2 trial sites

  • Phase 1MMP-1232024-10-28

    2 trial sites

  • Phase 1MMP-3182024-08-21

    1 trial site

  • BioequivalenceMMP-3192024-08-08

    2 trial sites

  • Phase 1MMP-3082023-10-19

    2 trial sites

  • BioequivalenceMMP-113정2023-07-21

    2 trial sites

  • Bioequivalence펜타씬정2023-04-24

    2 trial sites

  • Phase 3NVP-22032023-04-18

    16 trial sites

  • Phase 1MMP-1032023-04-13

    1 trial site

  • Bioequivalence레디펜정(펜터민염산염)2023-04-04

    2 trial sites

Show 43 more
  • Bioequivalence브로피딘정(레보드로프로피진)2023-02-10

    2 trial sites

  • Phase 3MMP-3052022-08-16

    4 trial sites

  • Bioequivalence명문클로피도그렐정(클로피도그렐황산염)2021-09-10

    1 trial site

  • Bioequivalence에스프롤정40밀리그램(에스오메프라졸마그네슘삼수화물)2021-04-19

    2 trial sites

  • Bioequivalence로젯정10/10밀리그램2020-06-24

    2 trial sites

  • Bioequivalence명문텔미로바정80/10mg(가칭)2019-12-10

    2 trial sites

  • Bioequivalence노피드캡슐(페노피브레이트 과립(미분화))2019-08-22

    2 trial sites

  • Bioequivalence에스프롤정40밀리그램(에스오메프라졸마그네슘삼수화물)2019-08-20

    2 trial sites

  • Bioequivalence더노피드정(페노피브레이트콜린)2019-02-13

    2 trial sites

  • Bioequivalence더노피드정(페노피브레이트콜린)2019-02-13

    2 trial sites

  • Bioequivalence명문록소프로펜정2018-12-05

    1 trial site

  • Bioequivalence명문쿠에티아핀정(쿠에티아핀푸마르산염)2018-11-30

    2 trial sites

  • Bioequivalence명문라사길린정(가칭)2018-11-26

    2 trial sites

  • Bioequivalence뉴라렌정(콜린알포세레이트)2018-09-07

    2 trial sites

  • Bioequivalence더노피드정(페노피브레이트콜린)2018-07-27

    2 trial sites

  • Bioequivalence더노피드정(페노피브레이트콜린)2018-01-15

    2 trial sites

  • Bioequivalence명문에스판토프라졸정20밀리그램(에스판토프라졸나트륨삼수화물)2017-10-13

    2 trial sites

  • Bioequivalence프릴린정150mg(프레가발린)2017-02-20

    2 trial sites

  • Bioequivalence명문아토르바스타틴정20mg2016-11-02

    2 trial sites

  • Bioequivalence명문클로피도그렐정(클로피도그렐황산수소염)2016-03-31

    2 trial sites

  • Bioequivalence본넬플러스정2015-12-03

    2 trial sites

  • Bioequivalence명문로수바스타틴칼슘정20밀리그램2015-10-23

    2 trial sites

  • Bioequivalence명문미르타자핀오디티정15밀리그램2015-09-21

    2 trial sites

  • Bioequivalence설트람정50밀리그램(설트랄린염산염)2015-07-16

    2 trial sites

  • Bioequivalence명문카모스타트메실산염100밀리그램(가칭)2015-02-27

    1 trial site

  • Bioequivalence명문세레콕시브캡슐(가칭)2014-10-15

    2 trial sites

  • Bioequivalence명문둘록세틴염산염캡슐60밀리그램(가칭)2014-08-27

    2 trial sites

  • Bioequivalence명문클로피도그렐정(클로피도그렐황산염)2014-07-23

    2 trial sites

  • Bioequivalence명문리스페리돈정1밀리그램2014-06-18

    2 trial sites

  • Bioequivalence테고캡슐 252014-04-28

    2 trial sites

  • Bioequivalence어코드레트로졸정2014-03-25

    2 trial sites

  • Bioequivalence명문라록시펜염산염정60mg(가칭)(라록시펜염산염60mg)2014-03-07

    1 trial site

  • Bioequivalence레티람정500mg(레비티라세탐)2013-11-20

    1 trial site

  • Bioequivalence셉트페질정10밀리그램(도네페질염산염)2013-05-13

    1 trial site

  • Bioequivalence명문레프루노미드정20mg(가칭)2013-03-21

    1 trial site

  • Bioequivalence본넬정35밀리그램(리세드론산나트륨2.5수화물)2013-02-05

    2 trial sites

  • Bioequivalence리바론패취10(리바스티그민)2012-12-27

    2 trial sites

  • BioequivalenceInvestigational drug not named2012-10-22
  • Bioequivalence에스토람정10mg2012-10-22

    2 trial sites

  • Bioequivalence명문발사르탄암로디핀정160/10mg(가칭)2012-08-09

    1 trial site

  • Bioequivalence텔미산플러스정40/12.5mg2012-07-11
  • Bioequivalence텔미산플러스정80/12.5mg2012-07-11

    2 trial sites

  • Bioequivalence명문라푸티딘정10mg2012-01-25

    2 trial sites

Global clinical trials

ClinicalTrials.gov · sponsor-matched

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 8 more patents

AI reads

MAA server logs · IP-verified
42
Times AI engines pulled MYUNGMOON PHARM CO.,LTD's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

2
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

40
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

6
live 1
Last 7 days
34
live 2
Last 30 days
42
live 2
All time
  • OpenAIChatGPT-Userlive2
  • OpenAIOAI-SearchBot33
  • GoogleGoogleOther2
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 8, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for MYUNGMOON PHARM CO.,LTD and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · products · R&D. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

DAIHAN SCIENTIFIC CO., Ltd1 shared

KOSDAQ-listed lab equipment company manufacturing and distributing ultra-low temperature freezers, centrifuges, and autoclaves.

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition